Dead Men Do Tell Tales: Tracking the Timeline of Genomic Drivers of Lethal Prostate Cancer in Living Metastatic Patients
Date/Time: Tuesday, February 4, 2020; 12-1 pm - Location: 13-105 CHS
Christopher Hovens, Ph.D. (Director of Scientific Research at the Australian Prostate Cancer Research Centre at Epworth Hospital and Royal Melbourne Hospital, and Professor and Principal Research Fellow in the Department of Surgery, University of Melbourne)
Professor Hovens has served as Chief Scientific Officer and main scientific advisor for two start up, drug development companies he has co-founded, Velacor Therapeutics Pty Ltd and CCH Pharma Pty Ltd. He is a co-inventor on 22 different patents and patent applications in the area of drug discovery and development ranging across indications from cancer to neurodegenerative disorders. His current research is focusing on the integrated genomic analysis of lethal prostate cancer phenotypes comparing disease progression samples within cohorts of patients, tracking and sampling the dispersed metastatic loci in patients followed by deep genomic analysis to retrace the timeline of genetic events that drive the lethal disease phenotype.
